Switch to:
More From Other Websites
Bayer/Regeneron Continue to Progress with Eylea Jul 22 2014
Coverage initiated on Regeneron Pharms by Argus Jul 21 2014
Regeneron to Report Second Quarter 2014 Financial and Operating Results and Host Conference Call and... Jul 18 2014
Regeneron to Report Second Quarter 2014 Financial and Operating Results and Host Conference Call and... Jul 18 2014
Gilead Sciences: Time For a Dividend? Jul 18 2014
InsiderInsights.com Daily Round Up: 7/17/14 Jul 18 2014
Two-Year Results From Phase 3 VIVID-DME Trial of EYLEA® (aflibercept) Injection for the Treatment... Jul 18 2014
Two-Year Results From Phase 3 VIVID-DME Trial of EYLEA® (aflibercept) Injection for the Treatment... Jul 18 2014
SHPG, REGN And LLY, 3 Drugs Stocks Pushing The Industry Lower Jul 16 2014
Gilead Sciences: The Senate Just Wrote Me a Letter Jul 11 2014
Sanofi/Regeneron Announce Encouraging Dupilumab Data Jul 10 2014
Regeneron's Dupilumab Drug Headed For Phase Three Tests Jul 10 2014
Regeneron Picked a Heck of a Day to Announce Good News Jul 10 2014
Cramer's Mad Money - The 4 Horsemen Of Biotech Ride On (7/9/14) Jul 10 2014
Jim Cramer's Top Stock Picks: WMB AA BIIB REGN CELG GILD UNUM Jul 10 2014
Valeant Is Hard to Stop Jul 10 2014
Cramer: 4 strong stocks for months to come Jul 09 2014
[video] Four horseman of biotech have a lot of upside: Cramer Jul 09 2014
In Small Trials, 2 Drugs Go Far in Soothing Symptoms of Eczema and Psoriasis Jul 09 2014


Add Notes, Comments or Ask Questions

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide